1-3 of 3
Raluca I. Verona
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity

Sangeetha Palakurthi, Mari Kuraguchi, Sima J. Zacharek, Enrique Zudaire, Wei Huang, Dennis M. Bonal, Jeffrey Liu, Abha Dhaneshwar, Kristin DePeaux, Martha R. Gowaski, Dyane Bailey, Samuel N. Regan, Elena Ivanova, Catherine Ferrante, Jessie M. English, Aditya Khosla, Andrew H. Beck, Julie A. Rytlewski, Catherine Sanders, Sylvie Laquerre, Mark A. Bittinger, Paul T. Kirschmeier, Kathryn Packman, Pasi A. Janne, Christopher Moy, Kwok-Kin Wong, Raluca I. Verona, Matthew V. Lorenzi
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2019) 7 (9): 1457–1471.
https://doi.org/10.1158/2326-6066.CIR-18-0595
Published: 03 September 2019
View article titled, The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity
Open the PDF for The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity in another window
Includes: Supplementary data
Journal Articles

Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity

Karla R. Wiehagen, Natasha M. Girgis, Douglas H. Yamada, Andressa A. Smith, Szeman Ruby Chan, Iqbal S. Grewal, Michael Quigley, Raluca I. Verona
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2017) 5 (12): 1109–1121.
https://doi.org/10.1158/2326-6066.CIR-17-0258
Published: 30 November 2017
View article titled, Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity
Open the PDF for Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity in another window
Includes: Supplementary data
Journal Articles

Abstract B27: Improved survival with erdafitinib (JNJ-42756493) and PD-1 blockade mediated by enhancement of anti-tumor immunity in an FGFR2-driven genetically engineered mouse model of lung cancer

Sangeetha Palakurthi, Mari Kuraguchi, Sima Zacharek, Jeff Liu, Dennis Bonal, Wei Huang, Kristin Depeaux, Abha Dhaneshwar, Sam Regan, Dyane Bailey, Martha Gowaski, Mei Zheng, Roderick Bronson, Catherine Ferrante, Enrique Zudaire, Sylvie Laquerre, Mark Bittinger, Kirschmeier Paul, Kathryn Packman, Raluca I. Verona, Kwok-Kin Wong, Matthew V. Lorenzi
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (3_Supplement): B27.
https://doi.org/10.1158/2326-6074.TUMIMM16-B27
Published: 28 February 2017
View article titled, Abstract B27: Improved survival with erdafitinib (JNJ-42756493) and PD-1 blockade mediated by enhancement of anti-tumor immunity in an FGFR2-driven genetically engineered mouse model of lung cancer